US Patent 7491716 Purine derivatives as kinase inhibitors
Patent 7491716 was granted and assigned to Eli Lilly on February, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Thomas Albert Engler0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+77 characters)
Article
Patent abstract
The present invention provides kinase inhibitors of Formula I.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07491716 Purine derivatives as kinase inhibitors US Patent 7491716 Purine derivatives as kinase inhibitors
Infobox
Patent Number
074917160
Patent Number
74917160
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074917160
Date of Patent
February 17, 2009
0Patent Application Number
105064590
Date Filed
March 4, 2003
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07491716 Purine derivatives as kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07491716
Date of patent
February 17, 2009
Patent application number
10506459
Date Filed
March 4, 2003
Patent primary examiner
Find more entities like US Patent 7491716 Purine derivatives as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
